ConductScience.org, home

Paper412691

The structural basis of the blood-ocular barriers.

Raviola G. Exp Eye Res, 1977. Cited by 289 papers, by iCite.

Cite this record

ConductScience Library. The structural basis of the blood-ocular barriers. Papers, record 412691. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/412691

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The structural basis of the blood-ocular barriers.
PubMed
Journal
Exp Eye Res
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
289
iCite
Relative citation ratio, by iCite
9.17
iCite
Revised in PubMed
2019-08-16
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Raviola GG

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EyeMajor topic
Animals
Anterior Chamber
Aqueous Humor
Biological Transport
Capillaries
Capillary Permeability
Choroid
Ciliary Body
Endothelium
Freeze Fracturing
Haplorhini
Intercellular Junctions
Iris
Microscopy, Electron
Pigment Epithelium of Eye
Rabbits
Retinal Vessels

Source PubMed

Download CSV of topics

Cited by81

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 289 citations.

PMIDTitleJournalYearIn PapersSource
42282114Checkpoint inhibition and beyond: Precision immune engineering for the immune-privileged landscape of ocular malignancies.Bioimpacts2026https://conductscience.org/library/papers/42282114PubMed
42261356Bridging Preclinical and Clinical Gaps in Ocular Therapeutics: Hydrogel Drug Delivery and 3D Tissue Models.Int J Nanomedicine2026https://conductscience.org/library/papers/42261356PubMed
41877771The Immunopathogenesis of uveitis.Front Med (Lausanne)2026https://conductscience.org/library/papers/41877771PubMed
41153322Cervical Oculopathy: The Cervical Spine Etiology of Visual Symptoms and Eye Diseases-A Hypothesis Exploring Mechanisms Linking the Neck and the Eye.Diagnostics (Basel)2025https://conductscience.org/library/papers/41153322PubMed
40718639Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases.Int J Nanomedicine2025https://conductscience.org/library/papers/40718639PubMed
40293397A Model of the Mechanisms Underpinning Unconventional Aqueous Humor Outflow.Invest Ophthalmol Vis Sci2025https://conductscience.org/library/papers/40293397PubMed
39943986Nanoparticles in intraocular drug delivery.Med Genet2025https://conductscience.org/library/papers/39943986PubMed
38206586The anterior chamber of the eye technology and its anatomical, optical, and immunological bases.Physiol Rev2024https://conductscience.org/library/papers/38206586PubMed
37569464Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation.Int J Mol Sci2023https://conductscience.org/library/papers/37569464PubMed
37530668Mass spectrometry in ocular drug research.Mass Spectrom Rev2026https://conductscience.org/library/papers/37530668PubMed
36965834Imaging ocular water inflow in the mouse with deuterium oxide MRI.Magn Reson Imaging2023https://conductscience.org/library/papers/36965834PubMed
36107200Nanomedicine and drug delivery to the retina: current status and implications for gene therapy.Naunyn Schmiedebergs Arch Pharmacol2022https://conductscience.org/library/papers/36107200PubMed
35729002Caveolar and non-Caveolar Caveolin-1 in ocular homeostasis and disease.Prog Retin Eye Res2022https://conductscience.org/library/papers/35729002PubMed
35283756Variability in Retinal Neuron Populations and Associated Variations in Mass Transport Systems of the Retina in Health and Aging.Front Aging Neurosci2022https://conductscience.org/library/papers/35283756PubMed
34769308Wnt Signaling in Inner Blood-Retinal Barrier Maintenance.Int J Mol Sci2021https://conductscience.org/library/papers/34769308PubMed
34379187Possible roles of anti-type II collagen antibody and innate immunity in the development and progression of diabetic retinopathy.Graefes Arch Clin Exp Ophthalmol2022https://conductscience.org/library/papers/34379187PubMed
34043907Ophthalmic Sensors and Drug Delivery.ACS Sens2021https://conductscience.org/library/papers/34043907PubMed
32923627Wnt signaling activates MFSD2A to suppress vascular endothelial transcytosis and maintain blood-retinal barrier.Sci Adv2020https://conductscience.org/library/papers/32923627PubMed
32678110Rapid assessment of ocular drug delivery in a novel ex vivo corneal model.Sci Rep2020https://conductscience.org/library/papers/32678110PubMed
32179994The anterior eye chamber: entry of the natural excretion pathway of gadolinium contrast agents?Eur Radiol2020https://conductscience.org/library/papers/32179994PubMed

See all 81 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/412691

GET https://conductscience.org/api/papers/v1/412691/cited_by?page=2